Hussman Strategic Advisors, Inc. Aurinia Pharmaceuticals Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $384 Million
- Q1 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 210,000 shares of AUPH stock, worth $1.73 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
210,000Holding current value
$1.73 Million% of portfolio
0.44%Shares
1 transactions
Others Institutions Holding AUPH
# of Institutions
233Shares Held
59.2MCall Options Held
949KPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$76.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$69.6 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$52.9 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.8 Million2.55% of portfolio
-
State Street Corp Boston, MA2.92MShares$24.1 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.17B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...